Neuromodulation market is expected to grow at a significant rate during the forecast period 2019-2025. Neuromodulation uses pharmaceutical agents, electrical signals, or other forms of energy for stimulating nerves by modulating abnormal neural pathway behavior caused by the disease. The neuromodulation treatment approach involves non-invasive techniques such as transcranial magnetic stimulation as well as implanted devices including spinal cord stimulation or a deep brain stimulation system. The global neuromodulation market is estimated to grow at a significant rate during the forecast period.
To Request a Sample of our Report on Neuromodulation market: https://www.omrglobal.com/request-sample/neuromodulation-market
The major factor that is contributing to the growth of the global neuromodulation market includes the increasing prevalence of neurological disorder. In addition, the rapid rise in the geriatric population pool further boosts the growth of the global neuromodulation market, as this population pool is more vulnerable to neurological disorders such as Alzheimer’s disease. Further, increasing awareness regarding the safety and efficacy of neurostimulator devices is also surging the growth of the global neuromodulations market. However, factors such as stringent government regulations, and a dearth of trained healthcare professionals serve as the major barriers in the growth of the market across the globe.
The global neuromodulation market is segmented on the basis of technology, application, and region. On the basis of technology, the market is further diversified into internal neuromodulation and external neuromodulation. Internal neuromodulation includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES), while external neuromodulation includes transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES). Moreover, on the basis of application, the market is further segmented into chronic pain, Parkinson’s disease, OCD, TRD, urinary and fecal disorder, and others.
Geographically, the market is analyzed into North America, Europe, Asia-Pacific and Rest of the World. Among these, North America is estimated to hold a significant share owing to the presence of a large population pool suffering from neurological disorders. In addition, the presence of major market players such as Abbott Laboratories Inc., and Boston Scientific Corp. further fuel the growth of the North American neuromodulation market. Moreover, Asia-Pacific is estimated to exhibit a significant growth rate during the forecast period owing to the increasing geriatric population in the region. Further, improving the healthcare infrastructure of the region also contribute to the growth in the Asia-Pacific region.
(Get 15% Discount on Buying this Report)
A full Report of Neuromodulation market is Available at: https://www.omrglobal.com/industry-reports/neuromodulation-market
Neuromodulation Market Segmentation
By Technology
- Internal Neuromodulation
- Spinal Cord Stimulation (SCS)
- Deep Brain Stimulation (DBS)
- Sacral Nerve Stimulation (SNS)
- Vagus Nerve Stimulation (VNS)
- Gastric Electrical Stimulation (GES)
- External Neuromodulation
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Transcranial Magnetic Stimulation (TMS)
- Respiratory Electrical Stimulation (RES)
By Application
- Chronic Pain
- Parkinson’s Disease
- Obsessive Compulsive Disorder (OCD)
- Treatment-Resistant Depression (TRD)
- Urinary and Fecal Disorders
- Others (Ischemia, Epilepsy)
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of The World
- Latin America
- Middle East & Africa
Company Profiles
- Abbott Laboratories Inc.
- Aleva Neurotherapeutics SA
- Bioness Inc.
- Boston Scientific Corp.
- Cogentix Medical, Inc.
- Cyberonics Inc.
- Integer Holdings Corp.
- LABORIE Medical Technologies Inc.
- LivaNova, PLC
- Medtronic PLC
- Neuronetics Inc.
- NeuroPace Inc.
- NeuroRecovery Technologies Inc.
- Neurosigma Inc.
- Neuspera Medical Inc.
- Nevro Corp.
- PathMaker Neurosystems Inc.
- Soterix Medical Inc.
- Synapse Biomedical Inc.
- Tivic Health Systems Inc.
- Xavant Technology
Reasons to Buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neuromodulation-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
